| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.002 | 0.9 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | -0.0022 | 0.9 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.002 | 0.9 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.0024 | 1 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |